Compass Therapeutics, Inc. · NASDAQ:CMPX
Vivo Opportunity Fund Holdings, L.P.'s stake in Compass Therapeutics, Inc. fell to 4.00% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Vivo Opportunity Fund Holdings, L.P.'s stake in Compass Therapeutics, Inc. fell to 4.00%, 7,207,573 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 7,207,573
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 4.00% | 7,207,573 |
| Vivo Opportunity, LLC | 4.00% | 7,207,573 |
| Vivo Opportunity Cayman Fund, L.P. | 0.30% | 549,487 |
| Vivo Opportunity Cayman, LLC | 0.30% | 549,487 |
Source
Related
- Compass Therapeutics, Inc.
- Vivo Opportunity, LLC
- Compass Therapeutics, Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Nov 14, 2025
- Form 4 · Lerner Neil · Oct 2, 2026
- Form 4 · Lerner Neil · Sep 25, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · Bvf Partners L P · May 15, 2026
- Form 4/A · Lerner Neil · Apr 30, 2026